Exservan

Active Ingredient(s): Riluzole
FDA Approved: * November 22, 2019
Pharm Company: * AQUESTIVE THERAP
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Exservan Overview

Riluzole is a medication used to treat amyotrophic lateral sclerosis. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months.[2] Riluzole is available in tablet and liquid form. Contents 1 Medical use 1.1 Amyotrophic lateral sclerosis 2 Adverse effects 2.1 Overdose 3 Contraindications 3.1 Interactions 4 Mechanism of action 5 Synthesis 6 Society and culture 6.1 Legal status 7 Research 8 Se...

Read more Exservan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Riluzole

Recent Exservan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Riluzole
  • Film: 50mg
  • Suspension: 50mg/10ml
  • Tablet: 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Exservan: (2 results)

Sorted by National Drug Code
  • 10094-350 Exservan 50 mg Oral Film by Aquestive Therapeutics
  • 70510-2201 Exservan 50 mg Oral Film by Mitsubishi Tanabe Pharma America, Inc.

Other drugs which contain Riluzole or a similar ingredient: (3 results)